News
A new study from the University of Maryland School of Medicine explores the consequences of sleep apnea on active-duty ...
8h
InvestorsHub on MSNVivos Therapeutics Shares Skyrocket After Medicare Greenlights VidaSleep Oral DeviceVivos Therapeutics Inc. (NASDAQ:VVOS) saw its stock soar by 90% following a major regulatory win: the company’s VidaSleep ...
Vivos’ portfolio of cutting-edge oral appliances offer a proprietary, clinically effective OSA solution that is nonsurgical, ...
Apnimed, Inc., a pharmaceutical company building the industry-leading portfolio of first-in-class oral drug candidates that address the root causes of obstructive sleep apnea (OSA) and other ...
Woodland Heights Medical Center is committed to helping patients get a better night's sleep, offering a surgical treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results